Exchange: NYSE·Updated 06:02 PM EDT

EVH Earnings

Latest Earnings Results: Q2 '26

Reported: Aug 06

Estimated EPS

-$0.01

Reported EPS

$0.02

Surprise

+292.1%

Estimated Rev

$597.69M

Reported Rev

$652.52M

Surprise

+9.17%

• Reported GAAP EPS of -$0.25 up 43.18% YoY • Reported revenue of $652.52M up 46.86% YoY • Evolent Health, Inc. is raising its 2026 revenue guidance range to $2.6 billion to $2.7 billion and is tightening its Adjusted EBITDA range to $120 million to $135 million for 2026.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
$0.06
--
--
N/A
Q2 '26
-$0.01
$0.02
292.10%
BEAT
Q1 '26
-$0.05
-$0.02
58.81%
BEAT
Q4 '25
$0.05
$0.08
56.56%
BEAT
Q3 '25
$0.10
$0.05
-51.18%
MISSED

Advertisement|Remove ads.